More importantly, RTKs that have remained poorly studied in the context of neuroblastoma pathogenesis, such as DDR2 and PDGFRA, are now revealed as very robust and potentially critical modulators of neuroblastoma. The gene discussed is PDGFRA; the disease is neuroblastoma.